TrialBMC medicine2022

A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial.

Jorge B Cannata-Andía et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.